Gastrointestinal complaints and hepatic symptoms are more common in patients ultimately diagnosed with COVID-19 than previously thought, according to a paper to be published in the journal Gastroenterology. The research, based on retrospective study of 1,059 patients at two hospitals in New York City, reveals that 33% of patients who went on to test positive for COVID-19 had at least one GI symptom at presentation; 22% had diarrhea, 7% had abdominal pain, 16% were nauseous, …
Read More